Esprit Pharma Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $370M

Esprit Pharma General Information

Description

Provider of medicine and products for the genito-urinary and women's healthcare markets. The company's medicine and products offers treatment for over-active bladder; urinary tract infections and to treat various symptoms of menopause, as well as PROSED, a line of urinary analgesic-antiseptic products, providing medical practitioners with a strategy for developing and marketing medicines to serve the unique needs of these physician specialities.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2 Tower Center Boulevard
  • Suite 9
  • East Brunswick, NJ 08816
  • United States
+1 (973)
Primary Industry
Pharmaceuticals
Corporate Office
  • 2 Tower Center Boulevard
  • Suite 9
  • East Brunswick, NJ 08816
  • United States
+1 (973)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Esprit Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 17-Oct-2007 $370M Completed Generating Revenue
3. Early Stage VC (Series B) 02-Aug-2006 Completed Generating Revenue
2. Debt - General 30-Apr-2006 $50M $55M Completed Generating Revenue
1. Early Stage VC (Series A) 06-Jun-2005 $5M $5M Completed Product Development
To view Esprit Pharma’s complete valuation and funding history, request access »

Esprit Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Esprit Pharma’s complete cap table history, request access »

Esprit Pharma Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Partners Venture Capital Minority
Apax Partners PE/Buyout Minority
Domain Associates Venture Capital Minority
Greenspring Associates Venture Capital Minority
New Enterprise Associates Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Esprit Pharma FAQs

  • When was Esprit Pharma founded?

    Esprit Pharma was founded in 2002.

  • Where is Esprit Pharma headquartered?

    Esprit Pharma is headquartered in East Brunswick, NJ.

  • What industry is Esprit Pharma in?

    Esprit Pharma’s primary industry is Pharmaceuticals.

  • Is Esprit Pharma a private or public company?

    Esprit Pharma is a Private company.

  • What is the current valuation of Esprit Pharma?

    The current valuation of Esprit Pharma is .

  • What is Esprit Pharma’s current revenue?

    The current revenue for Esprit Pharma is .

  • How much funding has Esprit Pharma raised over time?

    Esprit Pharma has raised $146M.

  • Who are Esprit Pharma’s investors?

    Alta Partners, Apax Partners, Domain Associates, Greenspring Associates, and New Enterprise Associates are 5 of 7 investors who have invested in Esprit Pharma.

  • When was Esprit Pharma acquired?

    Esprit Pharma was acquired on 17-Oct-2007.

  • Who acquired Esprit Pharma?

    Esprit Pharma was acquired by Allergan (Acquired 2015).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process